/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Amgen Inc.\n \n\n\n\n\n
Nov 22 7:25 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 19, 2009 4:01 PM EST
\n\n \n ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology - Business Wire\n \n \n
\n\n Nov 16, 2009 6:06 PM EST
\n\n \n Amgen to Present at Lazard Capital Healthcare Conference - PR Newswire\n \n \n
\n\n Nov 12, 2009 12:55 PM EST
\n\n \n CellCyte Genetics Corp. Announces the Appointment of Douglas P. Cerretti, Ph.D. as Chief Science Officer and Director of Business Development - Business Wire\n \n \n
\n\n Nov 12, 2009 9:26 AM EST
\n\n \n Critical Outcome Technologies Inc. Engages Pullan Consulting to Obtain a Licencing Deal for COTI-2 - Marketwire Canada\n \n \n
\n\n Nov 12, 2009 9:05 AM EST
\n\n \n Critical Outcome Technologies Inc. Engages Pullan Consulting to Obtain a Licencing Deal for COTI-2 - Marketwire\n \n \n
\n\n Nov 12, 2009 9:02 AM EST
\n\n \n Amgen to Present at 18th Annual Credit Suisse Healthcare Conference - PR Newswire\n \n \n
\n\n Nov 12, 2009 7:06 AM EST
\n\n \n Colorectal Cancer patients in Alberta and Saskatchewan Get a New Sense of Hope - CNW\n \n \n
\n
\n\n");